<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Endoscopic ultrasound for evaluating patients with esophageal cancer
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Endoscopic ultrasound for evaluating patients with esophageal cancer
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Endoscopic ultrasound for evaluating patients with esophageal cancer
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Maurits J Wiersema, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Douglas G Adler, MD, FACG, AGAF, FASGE
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kristen M Robson, MD, MBA, FACG
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Oct 18, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The prognosis of esophageal cancer is strongly associated with its stage, and the choice of initial treatment is highly dependent on clinical stage at diagnosis. As a result, accurate clinical staging is critical for selecting appropriate treatment options. Endoscopic ultrasonography (EUS) has a central role in the initial staging of esophageal carcinoma and may also be useful for detecting disease recurrence.
        </p>
        <p>
         This topic review will focus on the role of EUS in the care of patients with esophageal cancer. An overview of the diagnosis and staging of esophageal cancer is presented separately. (See
         <a class="medical medical_review" href="/z/d/html/2502.html" rel="external">
          "Clinical manifestations, diagnosis, and staging of esophageal cancer"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          PREOPERATIVE STAGING
         </span>
         <span class="headingEndMark">
          —
         </span>
         Initial evaluation of the patient diagnosed with esophageal cancer centers on the assessment of their operative risk and tumor stage. Preoperative tumor staging is warranted in patients who are potential surgical candidates because their disease extent will influence treatment planning (eg, it may reveal that a patient is a candidate for endoscopic resection). (See
         <a class="medical medical_review" href="/z/d/html/2530.html" rel="external">
          "Surgical management of resectable esophageal and esophagogastric junction cancers"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2494.html" rel="external">
          "Management of superficial esophageal cancer"
         </a>
         .)
        </p>
        <p>
         Neoadjuvant chemotherapy with or without radiotherapy is typically recommended, rather than upfront surgery, for those with locally advanced (ie, T3 and/or node-positive) tumors. (See
         <a class="medical medical_review" href="/z/d/html/2478.html" rel="external">
          "Radiation therapy, chemoradiotherapy, neoadjuvant approaches, and postoperative adjuvant therapy for localized cancers of the esophagus"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16226.html" rel="external">
          "Multimodality approaches to potentially resectable esophagogastric junction and gastric cardia adenocarcinomas"
         </a>
         .)
        </p>
        <p>
         Staging usually begins with a contrast-enhanced computed tomography (CT) scan of the neck, chest, and abdomen to evaluate for the presence of metastatic disease. However, with increasing availability, integrated fluorodeoxyglucose positron emission tomography (FDG-PET)/CT fusion scanning may be more accurate for the detection of stage IV disease and can be used as an initial staging assessment. (See
         <a class="medical medical_review" href="/z/d/html/2502.html" rel="external">
          "Clinical manifestations, diagnosis, and staging of esophageal cancer", section on 'Evaluation for distant metastases'
         </a>
         .)
        </p>
        <p>
         A more detailed evaluation of locoregional disease extent (T and N stage) should be obtained if distant metastases are not demonstrated on cross-sectional imaging. A number of studies have demonstrated that EUS is more accurate than transabdominal ultrasound, CT scan, magnetic resonance imaging (MRI), or PET scanning for locoregional staging of esophageal cancer [
         <a href="#rid1">
          1-17
         </a>
         ], with an overall accuracy of EUS for T and N staging of 90 percent [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p>
         Overall, study results will be influenced by the number of early versus advanced T-stage patients as EUS is more accurate in the latter population. A strong correlation exists between tumor differentiation, T-stage and lymph node status [
         <a href="#rid19">
          19
         </a>
         ]. A meta-analysis of diagnostic test characteristics made the following estimates for EUS, CT, and FDG-PET, concluding that the three approaches were complementary [
         <a href="#rid16">
          16
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For EUS, the sensitivity and specificity for detecting celiac lymph node metastases (considered regional lymph nodes in the staging classification, regardless of primary tumor location) were 85 percent (95% CI 72-99 percent) and 96 percent (95% CI 92-100 percent), respectively. Sensitivity and specificity for other regional lymph node metastases were 80 percent (95% CI 75-84 percent) and 70 percent (95% CI 65-75 percent), respectively.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For CT, sensitivity and specificity for regional lymph node metastases were 50 percent (95% CI 41-60 percent) and 83 percent (95% CI 77-89 percent), respectively. For abdominal lymph node metastases (ie, nonregional, nonceliac abdominal nodes), these values were 42 percent (95% CI 29-54 percent) and 93 percent (95% CI 86-100 percent), respectively. For distant metastases, these values were 52 percent (95% CI 33-71 percent) and 91 percent (95% CI 86-96 percent), respectively.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For FDG-PET, sensitivity and specificity for regional lymph node metastases were 57 percent (95% CI 43-70 percent) and 85 percent (95% CI 76-95 percent), respectively. For distant metastases, these values were 71 percent (95% CI 62-79 percent) and 93 percent (95% CI 89-97 percent), respectively.
        </p>
        <p>
        </p>
        <p>
         The tumor, node, metastasis staging system of the American Joint Committee on Cancer and the Union for International Cancer Control for esophageal cancer (adenocarcinoma and squamous cell carcinoma) is used universally (2017, eighth edition)  (
         <a class="graphic graphic_table graphicRef111221" href="/z/d/graphic/111221.html" rel="external">
          table 1A
         </a>
         and
         <a class="graphic graphic_table graphicRef62895" href="/z/d/graphic/62895.html" rel="external">
          table 1B
         </a>
         ) and has a slight difference in the definitions of T4a disease compared with the prior version [
         <a href="#rid20">
          20,21
         </a>
         ].
        </p>
        <p>
         In general, the EUS report should include the endoscopic findings of tumor location, features (eg, circumferential extent, skip areas, presence/absence of Barrett’s), and anatomic landmarks (gastroesophageal junction, diaphragmatic hiatus, squamocolumnar junction), length of tumor, luminal diameter, as well as a description incorporating the T-stage including maximal wall thickness, N-stage (as per guidelines using N0 - N3), and specific features of identified lymph nodes (location, shape/size/border/echogenicity) [
         <a href="#rid22">
          22
         </a>
         ]. Incomplete or limited staging due to tumoral stenosis should be described when present.
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          General principles of EUS imaging
         </span>
         <span class="headingEndMark">
          —
         </span>
         Dedicated echoendoscopes operating at frequencies of 7.5 and 12 MHz are able to visualize the esophageal wall as a five-layered structure  (
         <a class="graphic graphic_diagnosticimage graphicRef73301" href="/z/d/graphic/73301.html" rel="external">
          image 1
         </a>
         and
         <a class="graphic graphic_figure graphicRef56258" href="/z/d/graphic/56258.html" rel="external">
          figure 1
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         First hyperechoic layer: superficial mucosa
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Second hypoechoic layer: deep mucosa
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Third hyperechoic layer: submucosa
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fourth hypoechoic layer: muscularis propria
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fifth hyperechoic layer: adventitia
        </p>
        <p>
        </p>
        <p>
         The ability to visualize the five layers permits a detailed understanding of the degree of tumor infiltration into the wall layers, providing an assessment of the tumor stage (T stage)  (
         <a class="graphic graphic_table graphicRef111616" href="/z/d/graphic/111616.html" rel="external">
          table 2
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef72915 graphicRef72321 graphicRef77939 graphicRef75810" href="/z/d/graphic/72915.html" rel="external">
          image 2A-D
         </a>
         ) [
         <a href="#rid23">
          23
         </a>
         ]. However, one limitation of standard echoendoscopes is that they operate at relatively low frequency and, as a result, cannot visualize the muscularis mucosa [
         <a href="#rid24">
          24,25
         </a>
         ]. EUS miniprobes that scan at higher frequencies  (
         <a class="graphic graphic_picture graphicRef74641" href="/z/d/graphic/74641.html" rel="external">
          picture 1
         </a>
         ) provide more detailed visualization of the esophageal wall by displaying alternating hyperechoic (bright) and hypoechoic (dark) bands that correspond to the histologic layers [
         <a href="#rid26">
          26,27
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The first layer (hyperechoic) and second layer (hypoechoic) correspond to the interface with the lumen and mucosal epithelium
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The third layer (hyperechoic) and fourth layer (hypoechoic) correspond to deep mucosa (lamina propria)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The fifth layer (hyperechoic) and sixth layer (hypoechoic) correspond to the muscularis mucosa interface and muscularis mucosa
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The seventh layer (hyperechoic) is the submucosa
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The eighth layer (hypoechoic) is the inner layer of the muscularis propria
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The ninth layer (hyperechoic) corresponds to connective tissue and the interface between the muscle layers
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The tenth layer (hypoechoic) corresponds to the outer layer of the muscularis propria
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The eleventh layer (hyperechoic) is the serosa/adventitia
        </p>
        <p>
        </p>
        <p>
         This may have particular importance when evaluating superficial lesions for which nonsurgical therapy (such as endoscopic mucosal resection) is being considered. (See
         <a class="local">
          'EUS for T staging of superficial tumors'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          EUS for T staging of superficial tumors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Early esophageal cancers are those that are classified as Tis (high-grade dysplasia, which includes all noninvasive neoplastic epithelial that was formerly called carcinoma in situ) or T1 tumors, which are split into T1a and T1b subcategories depending on the depth of invasion  (
         <a class="graphic graphic_table graphicRef111221" href="/z/d/graphic/111221.html" rel="external">
          table 1A
         </a>
         and
         <a class="graphic graphic_table graphicRef62895" href="/z/d/graphic/62895.html" rel="external">
          table 1B
         </a>
         ). These are referred to as superficial esophageal cancers. The risk of nodal metastases is higher for T1b than T1a tumors, and within these subcategories, risk may be further stratified according to depth of invasion and the presence of lymphovascular invasion (LVI). (See
         <a class="medical medical_review" href="/z/d/html/2494.html" rel="external">
          "Management of superficial esophageal cancer", section on 'Pathologic subclassification and the risk of nodal metastases'
         </a>
         .)
        </p>
        <p>
         The role of EUS for T staging and subsequent management of superficial tumors has been controversial. If the EUS identifies only mucosal (T1a) disease, endoscopic mucosal resection is usually the next step to remove the tumor and precisely define the depth of invasion. The pathology result from the endoscopic mucosal resection (particularly the presence or absence of LVI) can then be used to guide the decision as to whether endoscopic therapy alone is sufficient or if surgery should be performed. On the other hand, if the EUS identifies esophageal cancer that invades beyond the muscularis mucosa (T1b), or if there is evidence of lymph node involvement, then the patient usually undergoes surgical resection. (See
         <a class="medical medical_review" href="/z/d/html/2530.html" rel="external">
          "Surgical management of resectable esophageal and esophagogastric junction cancers"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2478.html" rel="external">
          "Radiation therapy, chemoradiotherapy, neoadjuvant approaches, and postoperative adjuvant therapy for localized cancers of the esophagus"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2494.html" rel="external">
          "Management of superficial esophageal cancer"
         </a>
         .)
        </p>
        <p>
         Studies on the accuracy of EUS for staging superficial esophageal cancer are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2494.html" rel="external">
          "Management of superficial esophageal cancer", section on 'Accuracy of EUS in the staging evaluation'
         </a>
         .)
        </p>
        <p>
         Although T1 lesions can be identified using echoendoscopes operating at 7.5 and 12 MHz, distinguishing subgroups of the T1 stage (muscularis mucosa and/or submucosal invasion)  (
         <a class="graphic graphic_figure graphicRef64349" href="/z/d/graphic/64349.html" rel="external">
          figure 2
         </a>
         ) can be problematic with these instruments because the frequencies are too low to visualize the muscularis mucosa. Small caliber ultrasound probes (commonly referred to as miniprobes or EUS miniprobes) scan at higher frequencies (12 to 20 MHz) than conventional echoendoscopes, and this results in high-resolution imaging but with a limited penetration depth of approximately 20 mm. The technical aspects and use of EUS miniprobes for determining disease extent in patients with superficial esophageal cancer are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2679.html" rel="external">
          "Endoscopic ultrasound (EUS): Use of miniprobes for evaluating gastrointestinal lesions"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          EUS for staging locally advanced tumors
         </span>
         <span class="headingEndMark">
          —
         </span>
         The large caliber of dedicated radial echoendoscopes (12.7 mm in diameter) may preclude complete EUS staging in patients with locally advanced esophageal tumors, which may be associated with esophageal stenosis. This was illustrated in a series of 113 patients who underwent esophagectomy in whom the accuracy of EUS for T and N staging was much higher for traversable (81 and 86 percent, respectively) as compared with nontraversable tumors (28 and 72 percent, respectively) [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p>
         Several options are available to improve accuracy in these settings:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Although dilation of the esophageal lumen to a diameter of 14 to 16 mm with either a Savary dilator or a controlled radial expansion (CRE) balloon has been described, we typically do not dilate malignant esophageal strictures because of the high risk of perforation (up to 24 percent) [
         <a href="#rid28">
          28-31
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Our practice is to perform endoscopy with a standard gastroscope initially at the time of EUS. If the gastroscope cannot traverse the stenosis, we do not dilate the lesion, as we infrequently are able to pass the echoendoscope even with this intervention. For patients with circumferential stenosis permitting passage of a gastroscope but not the echoendoscope, we may very carefully dilate the lesion. We are particularly cautious when semi-circumferential involvement is present, since the normal (and hence thinner) esophageal wall may be at increased risk of tearing in this setting, particularly if the proximal esophagus is dilated.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ultrasound catheters introduced through the biopsy channel of the endoscope may traverse tight strictures due to their small caliber (3 mm in maximum diameter). Although this may improve the accuracy of T and N staging [
         <a href="#rid32">
          32
         </a>
         ], limited depth of penetration can lead to incomplete assessment of locoregional spread. (See
         <a class="medical medical_review" href="/z/d/html/2679.html" rel="external">
          "Endoscopic ultrasound (EUS): Use of miniprobes for evaluating gastrointestinal lesions"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3090718733">
         <span class="h2">
          Accuracy of EUS for determining unresectability
         </span>
         <span class="headingEndMark">
          —
         </span>
         The definition of a T4 tumor has been refined in 2017 guidelines. In the staging classification, tumors staged as T4b are considered unresectable, while advanced tumors (T4a) at EUS typically results in chemoradiation (in the absence of distant metastases) followed by restaging and surgical resection if possible [
         <a href="#rid33">
          33
         </a>
         ]. In the guidelines, T4a tumors include tumors involving the pleura, pericardium, diaphragm for both SCC and adenocarcinomas  (
         <a class="graphic graphic_table graphicRef111221 graphicRef62895" href="/z/d/graphic/111221.html" rel="external">
          table 1A-B
         </a>
         ), and for adenocarcinomas of the distal esophagus and esophagogastric junction (EGJ), they include tumors invading the azygos vein, diaphragm, or peritoneum [
         <a href="#rid34">
          34
         </a>
         ].
        </p>
        <p>
         Unresectability is also suggested by EUS in patients with tumors arising above the level of the carina, with extension through the esophageal wall into the mediastinum. It may be difficult or impossible to obtain a safe margin of resection between the tumor and the trachea and/or bifurcation in such patients [
         <a href="#rid35">
          35
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1630970832">
         <span class="h2">
          EUS for preoperative lymph node staging
         </span>
         <span class="headingEndMark">
          —
         </span>
         Endosonographic criteria that are suggestive of malignant involvement of visible lymph nodes include a width greater than 10 mm, round shape, smooth border, and echo-poor pattern  (
         <a class="graphic graphic_table graphicRef66591" href="/z/d/graphic/66591.html" rel="external">
          table 3
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef57813" href="/z/d/graphic/57813.html" rel="external">
          image 3
         </a>
         ) [
         <a href="#rid36">
          36,37
         </a>
         ]. Of these, an echo-poor pattern and width &gt;10 mm appear to be the most specific for malignancy. When all four suspicious features are present in a visualized lymph node, there is an 80 to 100 percent chance of metastatic involvement [
         <a href="#rid36">
          36,37
         </a>
         ]. However, only 25 percent of malignant nodes will have all of these features. These results demonstrate the limitations of EUS criteria for preoperative determination of lymph node staging, especially if the nodes are small.
        </p>
        <p>
         The lymph node stage is further categorized according to the number of involved nodes (no involved nodes (N0), 1 or 2 (N1), 3 to 6 (N2), and 7 or more (N3)) involved lymph nodes, but not the location of the nodes. However, most EUS/CT/PET staging studies have not included this refinement when reporting N staging accuracy.
        </p>
        <p>
         As noted above, EUS has an accuracy of more than 80 percent for detecting malignant nodes in the cervical paraesophageal, right recurrent laryngeal, left paratracheal, upper and lower paraesophageal, infra-aortic, infracarinal, lower posterior mediastinal, and perigastric regions. Greater numbers of malignant-appearing periesophageal lymph nodes detected by EUS predicted worse survival [
         <a href="#rid38">
          38,39
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2502.html" rel="external">
          "Clinical manifestations, diagnosis, and staging of esophageal cancer"
         </a>
         .)
        </p>
        <p>
         The demonstration of clinically suspicious lymph nodes may support the selection of induction chemoradiotherapy over surgery alone, particularly in a patient with T2 disease [
         <a href="#rid40">
          40
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2478.html" rel="external">
          "Radiation therapy, chemoradiotherapy, neoadjuvant approaches, and postoperative adjuvant therapy for localized cancers of the esophagus"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h3">
          Endoscopic ultrasound-guided fine-needle aspiration biopsy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Endoscopic ultrasound-guided fine-needle aspiration (EUS FNA) may improve the accuracy of N staging by providing cytologic confirmation of metastatic disease from accessible nodes, as long as the primary tumor is not in the pathway of the aspiration needle. EUS FNA cytology results may not be reliable if the needle has to traverse the primary tumor.
        </p>
        <p>
         Although staging studies with EUS in esophageal carcinoma have utilized EUS FNA, subsequent data have suggested that accuracy of EUS-guided fine needle biopsy (FNB) and EUS FNA are similar for evaluating solid lesions and that EUS FNB may have advantages with respect to efficiency [
         <a href="#rid41">
          41
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2656.html" rel="external">
          "Endoscopic ultrasound-guided fine needle aspiration in the gastrointestinal tract"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2649.html" rel="external">
          "Endoscopic ultrasound-guided fine needle biopsy in the gastrointestinal tract"
         </a>
         .)
        </p>
        <p>
         Sensitivity, specificity, and accuracy of EUS FNA for locoregional lymph nodes are all over 85 percent when surgical resection specimen or cytology results are considered as the gold standard [
         <a href="#rid42">
          42-44
         </a>
         ]. The accuracy of EUS FNA for esophageal cancer staging appears to be similar to that reported for other gastrointestinal malignancies  (
         <a class="graphic graphic_table graphicRef73448" href="/z/d/graphic/73448.html" rel="external">
          table 4
         </a>
         ) [
         <a href="#rid45">
          45-48
         </a>
         ].
        </p>
        <p>
         EUS FNA appears to improve the accuracy of nodal staging beyond that achieved by EUS alone. One study compared lymph node staging using EUS alone in a historical cohort of 33 patients versus 31 patients who underwent EUS FNA of non-peritumoral lymph nodes for preoperative lymph node staging [
         <a href="#rid47">
          47
         </a>
         ]. Compared with EUS alone, EUS FNA was associated with significantly better sensitivity (93 versus 63 percent) and accuracy (93 versus 70 percent). A comparison of specificity was limited in this study, since only one patient underwent a biopsy for which benign pathology was reported. EUS FNA was less costly than CT FNA and surgery. The cost-saving was principally a result of a reduction in unnecessary surgery [
         <a href="#rid49">
          49
         </a>
         ].
        </p>
        <p>
         These results were supported by a prospective study that compared the performance characteristics of CT, EUS, and EUS FNA for preoperative lymph node staging of esophageal carcinoma in 125 patients [
         <a href="#rid50">
          50
         </a>
         ]. EUS FNA was more sensitive than CT (83 versus 29 percent) and more accurate than CT (87 versus 51 percent) or EUS (87 versus 74 percent) for nodal staging  (
         <a class="graphic graphic_table graphicRef73600" href="/z/d/graphic/73600.html" rel="external">
          table 5
         </a>
         ). Direct surgical resection was contraindicated in 77 percent of patients due to detection of advanced locoregional/metastatic disease.
        </p>
        <p>
         Optimal criteria for identifying malignant lymph nodes based upon EUS criteria and for helping to select patients for whom EUS FNA is required continue to evolve. Initial experience suggests that a selective approach based on modified EUS criteria was cost-saving compared with an approach of routine FNA [
         <a href="#rid51">
          51
         </a>
         ]. Furthermore, the modified EUS criteria (four standard criteria plus EUS-identified celiac lymph nodes, &gt;5 lymph nodes, or EUS T3/4 tumor) were more accurate than standard criteria (hypoechoic, smooth border, round, or width &gt;5 mm) at identifying malignant lymph nodes.
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Interobserver variation and EUS learning curve
         </span>
         <span class="headingEndMark">
          —
         </span>
         The accuracy of EUS is operator-dependent [
         <a href="#rid52">
          52
         </a>
         ]. Interobserver reliability (different observers staging the same patients) is influenced by experience and tumor stage [
         <a href="#rid18">
          18,53-56
         </a>
         ]. Technical factors, including balloon overinflation causing a blurring of the distinction between the esophageal wall layers, tangential imaging, and inadequate use of higher scanning frequencies (12 MHz), may be responsible for staging errors among inexperienced endosonographers [
         <a href="#rid54">
          54,56,57
         </a>
         ].
        </p>
        <p>
         Among expert endosonographers (&gt;75 esophageal cancer examinations) [
         <a href="#rid58">
          58
         </a>
         ], overstaging of esophageal carcinomas is more frequent than understaging, occurring in 8 to 14 percent of patients [
         <a href="#rid59">
          59
         </a>
         ]. This is particularly evident in T2 lesions and may be attributed to peritumoral inflammation leading to an overestimation of mural penetration [
         <a href="#rid59">
          59
         </a>
         ]. In contrast, understaging occurs in 3 to 15 percent of cases and is frequently associated with T3 tumors with microscopic infiltration of the adventitia that is beyond the resolution capabilities of the available echoendoscopes [
         <a href="#rid8">
          8,56
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h1">
          RESTAGING AFTER NEOADJUVANT THERAPY
         </span>
         <span class="headingEndMark">
          —
         </span>
         One of the most controversial areas in oncology has been the optimal treatment of potentially resectable esophageal cancer, in particular, the benefit of multimodality therapy (ie, preoperative chemoradiotherapy or perioperative chemotherapy alone over resection alone). However, clinical practice is evolving toward initial (neoadjuvant) therapy rather than resection for tumors that are T3 and/or node-positive at presentation. (See
         <a class="medical medical_review" href="/z/d/html/2478.html" rel="external">
          "Radiation therapy, chemoradiotherapy, neoadjuvant approaches, and postoperative adjuvant therapy for localized cancers of the esophagus"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16226.html" rel="external">
          "Multimodality approaches to potentially resectable esophagogastric junction and gastric cardia adenocarcinomas"
         </a>
         .)
        </p>
        <p>
         For patients who undergo preoperative chemoradiotherapy or chemotherapy alone, it is frequently desirable to evaluate the response to treatment prior to recommending tumor resection [
         <a href="#rid60">
          60,61
         </a>
         ]. Unfortunately, the accuracy of endoscopic ultrasound (EUS) is limited in this setting. As an example, in a meta-analysis involving 16 studies with 724 patients, the pooled sensitivity and specificity of EUS in staging esophageal cancer after neoadjuvant chemotherapy varied with tumor stage  (
         <a class="graphic graphic_table graphicRef111616" href="/z/d/graphic/111616.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid60">
          60
         </a>
         ]. The sensitivity was relatively high in T3 disease (81 percent), while specificity was high in other T stages (T1, T2, and T4). Results did not appreciably change over time despite introduction of more sophisticated technology. A possible explanation for the discrepancy between endoscopic and subsequent pathologic staging is that EUS may not be able to differentiate between post-treatment inflammation/fibrosis and residual tumor.
        </p>
        <p class="headingAnchor" id="H2580706585">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/120117.html" rel="external">
          "Society guideline links: Esophageal cancer"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Background
         </strong>
         – The prognosis of esophageal cancer is strongly associated with its stage, and the choice of initial treatment is highly dependent on clinical stage at diagnosis. As a result, accurate clinical staging is critical for selecting appropriate treatment options. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preoperative staging
         </strong>
         – Endoscopic ultrasonography (EUS) is the most accurate method for locoregional staging of esophageal cancer. EUS should be performed to assess T and N stage in patients being considered for surgery once distant metastases have been excluded by computed tomography and/or integrated fluorodeoxyglucose positron emission tomography (FDG/PET)/CT scan. The addition of EUS-guided fine-needle aspiration has further improved lymph node staging accuracy and should be performed routinely when confirmation of metastatic lymphadenopathy will alter the approach to treatment. In addition, studies have suggested that EUS-guided fine needle biopsy is an accurate alternative for tissue sampling in this setting. (See
         <a class="local">
          'Preoperative staging'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/2656.html" rel="external">
          "Endoscopic ultrasound-guided fine needle aspiration in the gastrointestinal tract"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2649.html" rel="external">
          "Endoscopic ultrasound-guided fine needle biopsy in the gastrointestinal tract"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other clinical applications
         </strong>
         – Limitations caused by locally advanced, stenotic tumors that preclude echoendoscope passage and, therefore, complete staging, are being overcome by smaller caliber instruments. (See
         <a class="medical medical_review" href="/z/d/html/2679.html" rel="external">
          "Endoscopic ultrasound (EUS): Use of miniprobes for evaluating gastrointestinal lesions"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Reports comparing EUS with PET support the superior performance of EUS in locoregional staging. However, EUS has a limited role in restaging patients post chemotherapy and/or radiation therapy. (See
         <a class="local">
          'Restaging after neoadjuvant therapy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The clinical manifestations, diagnosis, and staging of esophageal cancer are presented in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/2502.html" rel="external">
          "Clinical manifestations, diagnosis, and staging of esophageal cancer"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H564171243">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The author and UpToDate thank Dr. Enrique Vazquez-Sequeiros, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Flamen P, Lerut A, Van Cutsem E, et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 2000; 18:3202.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keswani RN, Early DS, Edmundowicz SA, et al. Routine positron emission tomography does not alter nodal staging in patients undergoing EUS-guided FNA for esophageal cancer. Gastrointest Endosc 2009; 69:1210.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tio TL, Coene PP, den Hartog Jager FC, Tytgat GN. Preoperative TNM classification of esophageal carcinoma by endosonography. Hepatogastroenterology 1990; 37:376.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dittler HJ, Bollschweiler E, Siewert JR. [What is the value of endosonography in the preoperative staging of esophageal carcinoma?]. Dtsch Med Wochenschr 1991; 116:561.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vilgrain V, Mompoint D, Palazzo L, et al. Staging of esophageal carcinoma: comparison of results with endoscopic sonography and CT. AJR Am J Roentgenol 1990; 155:277.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Botet JF, Lightdale CJ, Zauber AG, et al. Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT. Radiology 1991; 181:426.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grimm H, Binmoeller KF, Hamper K, et al. Endosonography for preoperative locoregional staging of esophageal and gastric cancer. Endoscopy 1993; 25:224.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rösch T, Lorenz R, Zenker K, et al. Local staging and assessment of resectability in carcinoma of the esophagus, stomach, and duodenum by endoscopic ultrasonography. Gastrointest Endosc 1992; 38:460.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quint LE, Glazer GM, Orringer MB. Esophageal imaging by MR and CT: study of normal anatomy and neoplasms. Radiology 1985; 156:727.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Petrillo R, Balzarini L, Bidoli P, et al. Esophageal squamous cell carcinoma: MRI evaluation of mediastinum. Gastrointest Radiol 1990; 15:275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Takashima S, Takeuchi N, Shiozaki H, et al. Carcinoma of the esophagus: CT vs MR imaging in determining resectability. AJR Am J Roentgenol 1991; 156:297.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lehr L, Rupp N, Siewert JR. Assessment of resectability of esophageal cancer by computed tomography and magnetic resonance imaging. Surgery 1988; 103:344.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koch J, Halvorsen RA Jr. Staging of esophageal cancer: computed tomography, magnetic resonance imaging, and endoscopic ultrasound. Semin Roentgenol 1994; 29:364.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rösch T. Endosonographic staging of esophageal cancer: a review of literature results. Gastrointest Endosc Clin N Am 1995; 5:537.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lowe VJ, Booya F, Fletcher JG, et al. Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer. Mol Imaging Biol 2005; 7:422.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Vliet EP, Heijenbrok-Kal MH, Hunink MG, et al. Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer 2008; 98:547.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Takizawa K, Matsuda T, Kozu T, et al. Lymph node staging in esophageal squamous cell carcinoma: a comparative study of endoscopic ultrasonography versus computed tomography. J Gastroenterol Hepatol 2009; 24:1687.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee WC, Lee TH, Jang JY, et al. Staging accuracy of endoscopic ultrasound performed by nonexpert endosonographers in patients with resectable esophageal squamous cell carcinoma: is it possible? Dis Esophagus 2015; 28:574.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rice TW, Ishwaran H, Hofstetter WL, et al. Esophageal Cancer: Associations With (pN+) Lymph Node Metastases. Ann Surg 2017; 265:122.
          </a>
         </li>
         <li class="breakAll">
          Rice TW, Kelsen D, Blackstone EH, et al. Esophagus and esophagogastric junction. In: AJCC Cancer Staging Manual, 8th ed, Amin MB (Ed), AJCC, Chicago 2017. p.185. Corrected at 4th printing, 2018.
         </li>
         <li class="breakAll">
          Ajani JA, In H, Sano T, et al. Stomach. In: AJCC Cancer Staging Manual, 8th ed, Amin MB (Ed), AJCC, Chicago 2017. p.203.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Varghese TK Jr, Hofstetter WL, Rizk NP, et al. The society of thoracic surgeons guidelines on the diagnosis and staging of patients with esophageal cancer. Ann Thorac Surg 2013; 96:346.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kimmey MB, Martin RW, Haggitt RC, et al. Histologic correlates of gastrointestinal ultrasound images. Gastroenterology 1989; 96:433.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hasegawa N, Niwa Y, Arisawa T, et al. Preoperative staging of superficial esophageal carcinoma: comparison of an ultrasound probe and standard endoscopic ultrasonography. Gastrointest Endosc 1996; 44:388.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murata Y, Suzuki S, Ohta M, et al. Small ultrasonic probes for determination of the depth of superficial esophageal cancer. Gastrointest Endosc 1996; 44:23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tajima Y, Nakanishi Y, Ochiai A, et al. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors. Cancer 2000; 88:1285.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seifert H, Fusaroli P, Arcidiacono PG, et al. Controversies in EUS: Do we need miniprobes? Endosc Ultrasound 2021; 10:246.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Catalano MF, Van Dam J, Sivak MV Jr. Malignant esophageal strictures: staging accuracy of endoscopic ultrasonography. Gastrointest Endosc 1995; 41:535.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kallimanis GE, Gupta PK, al-Kawas FH, et al. Endoscopic ultrasound for staging esophageal cancer, with or without dilation, is clinically important and safe. Gastrointest Endosc 1995; 41:540.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Dam J, Rice TW, Catalano MF, et al. High-grade malignant stricture is predictive of esophageal tumor stage. Risks of endosonographic evaluation. Cancer 1993; 71:2910.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wallace MB, Hawes RH, Sahai AV, et al. Dilation of malignant esophageal stenosis to allow EUS guided fine-needle aspiration: safety and effect on patient management. Gastrointest Endosc 2000; 51:309.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Menzel J, Hoepffner N, Nottberg H, et al. Preoperative staging of esophageal carcinoma: miniprobe sonography versus conventional endoscopic ultrasound in a prospective histopathologically verified study. Endoscopy 1999; 31:291.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kosugi S, Ichikawa H, Kanda T, et al. Clinicopathological characteristics and prognosis of patients with esophageal carcinoma invading adjacent structures found during esophagectomy. J Surg Oncol 2012; 105:767.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rice TW, Ishwaran H, Ferguson MK, et al. Cancer of the Esophagus and Esophagogastric Junction: An Eighth Edition Staging Primer. J Thorac Oncol 2017; 12:36.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dittler HJ. Assessment of resectability of gastrointestinal cancers by endoscopic ultrasonography. Gastrointest Endosc Clin N Am 1995; 5:569.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Catalano MF, Sivak MV Jr, Rice T, et al. Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc 1994; 40:442.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bhutani MS, Hawes RH, Hoffman BJ. A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration for diagnosis of malignant lymph node invasion. Gastrointest Endosc 1997; 45:474.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen J, Xu R, Hunt GC, et al. Influence of the number of malignant regional lymph nodes detected by endoscopic ultrasonography on survival stratification in esophageal adenocarcinoma. Clin Gastroenterol Hepatol 2006; 4:573.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Twine CP, Roberts SA, Rawlinson CE, et al. Prognostic significance of the endoscopic ultrasound defined lymph node metastasis count in esophageal cancer. Dis Esophagus 2010; 23:652.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rice TW, Blackstone EH, Adelstein DJ, et al. Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinoma. J Thorac Cardiovasc Surg 2003; 125:1091.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Riet PA, Erler NS, Bruno MJ, Cahen DL. Comparison of fine-needle aspiration and fine-needle biopsy devices for endoscopic ultrasound-guided sampling of solid lesions: a systemic review and meta-analysis. Endoscopy 2021; 53:411.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wiersema MJ, Vilmann P, Giovannini M, et al. Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology 1997; 112:1087.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Giovannini M, Seitz JF, Monges G, et al. Fine-needle aspiration cytology guided by endoscopic ultrasonography: results in 141 patients. Endoscopy 1995; 27:171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eloubeidi MA, Wallace MB, Reed CE, et al. The utility of EUS and EUS-guided fine needle aspiration in detecting celiac lymph node metastasis in patients with esophageal cancer: a single-center experience. Gastrointest Endosc 2001; 54:714.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reed CE, Mishra G, Sahai AV, et al. Esophageal cancer staging: improved accuracy by endoscopic ultrasound of celiac lymph nodes. Ann Thorac Surg 1999; 67:319.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Giovannini M, Monges G, Seitz JF, et al. Distant lymph node metastases in esophageal cancer: impact of endoscopic ultrasound-guided biopsy. Endoscopy 1999; 31:536.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vazquez-Sequeiros E, Norton ID, Clain JE, et al. Impact of EUS-guided fine-needle aspiration on lymph node staging in patients with esophageal carcinoma. Gastrointest Endosc 2001; 53:751.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Catalano MF, Alcocer E, Chak A, et al. Evaluation of metastatic celiac axis lymph nodes in patients with esophageal carcinoma: accuracy of EUS. Gastrointest Endosc 1999; 50:352.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harewood GC, Wiersema MJ. A cost analysis of endoscopic ultrasound in the evaluation of esophageal cancer. Am J Gastroenterol 2002; 97:452.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vazquez-Sequeiros E, Wiersema MJ, Clain JE, et al. Impact of lymph node staging on therapy of esophageal carcinoma. Gastroenterology 2003; 125:1626.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vazquez-Sequeiros E, Levy MJ, Clain JE, et al. Routine vs. selective EUS-guided FNA approach for preoperative nodal staging of esophageal carcinoma. Gastrointest Endosc 2006; 63:204.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Vliet EP, Eijkemans MJ, Poley JW, et al. Staging of esophageal carcinoma in a low-volume EUS center compared with reported results from high-volume centers. Gastrointest Endosc 2006; 63:938.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Catalano MF, Sivak MV Jr, Bedford RA, et al. Observer variation and reproducibility of endoscopic ultrasonography. Gastrointest Endosc 1995; 41:115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burtin P, Berg P, Bour B, et al. [Evaluation of the teaching of echo-endoscopy. Application to the assessment of invasiveness of cancer of the esophagus and the cardia]. Gastroenterol Clin Biol 1995; 19:15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Palazzo L, Burtin P. Interobserver variation in tumor staging. Gastrointest Endosc Clin N Am 1995; 5:559.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fockens P, Van den Brande JH, van Dullemen HM, et al. Endosonographic T-staging of esophageal carcinoma: a learning curve. Gastrointest Endosc 1996; 44:58.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Massari M, Cioffi U, De Simone M, et al. Endoscopic ultrasonography for preoperative staging of esophageal carcinoma. Surg Laparosc Endosc 1997; 7:162.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schlick T, Heintz A, Junginger T. The examiner's learning effect and its influence on the quality of endoscopic ultrasonography in carcinoma of the esophagus and gastric cardia. Surg Endosc 1999; 13:894.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Souquet JC, Napoleon B, Pujol B, et al. Endosonography-guided treatment of esophageal carcinoma. Endoscopy 1992; 24 Suppl 1:324.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sun F, Chen T, Han J, et al. Staging accuracy of endoscopic ultrasound for esophageal cancer after neoadjuvant chemotherapy: a meta-analysis and systematic review. Dis Esophagus 2015; 28:757.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang WL, Wang WL, Chung TJ, et al. Response evaluation with endoscopic ultrasound and computed tomography in esophageal squamous cell carcinoma treated by definitive chemoradiotherapy. J Gastroenterol Hepatol 2015; 30:463.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 2663 Version 25.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10986052" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19012886" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Routine positron emission tomography does not alter nodal staging in patients undergoing EUS-guided FNA for esophageal cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2210603" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Preoperative TNM classification of esophageal carcinoma by endosonography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2013262" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : [What is the value of endosonography in the preoperative staging of esophageal carcinoma?].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2115251" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Staging of esophageal carcinoma: comparison of results with endoscopic sonography and CT.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1924784" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8519241" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Endosonography for preoperative locoregional staging of esophageal and gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1511822" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Local staging and assessment of resectability in carcinoma of the esophagus, stomach, and duodenum by endoscopic ultrasonography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4023234" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Esophageal imaging by MR and CT: study of normal anatomy and neoplasms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2210193" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Esophageal squamous cell carcinoma: MRI evaluation of mediastinum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1898802" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Carcinoma of the esophagus: CT vs MR imaging in determining resectability.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3344487" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Assessment of resectability of esophageal cancer by computed tomography and magnetic resonance imaging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7809650" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Staging of esophageal cancer: computed tomography, magnetic resonance imaging, and endoscopic ultrasound.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7582580" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Endosonographic staging of esophageal cancer: a review of literature results.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16270235" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18212745" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Staging investigations for oesophageal cancer: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19788609" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Lymph node staging in esophageal squamous cell carcinoma: a comparative study of endoscopic ultrasonography versus computed tomography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24835402" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Staging accuracy of endoscopic ultrasound performed by nonexpert endosonographers in patients with resectable esophageal squamous cell carcinoma: is it possible?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28009736" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Esophageal Cancer: Associations With (pN+) Lymph Node Metastases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28009736" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Esophageal Cancer: Associations With (pN+) Lymph Node Metastases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28009736" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Esophageal Cancer: Associations With (pN+) Lymph Node Metastases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23752201" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : The society of thoracic surgeons guidelines on the diagnosis and staging of patients with esophageal cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2642877" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Histologic correlates of gastrointestinal ultrasound images.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8905355" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Preoperative staging of superficial esophageal carcinoma: comparison of an ultrasound probe and standard endoscopic ultrasonography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8836712" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Small ultrasonic probes for determination of the depth of superficial esophageal cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10717608" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34380805" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Controversies in EUS: Do we need miniprobes?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7672544" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Malignant esophageal strictures: staging accuracy of endoscopic ultrasonography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7672545" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Endoscopic ultrasound for staging esophageal cancer, with or without dilation, is clinically important and safe.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8490818" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : High-grade malignant stricture is predictive of esophageal tumor stage. Risks of endosonographic evaluation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10699776" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Dilation of malignant esophageal stenosis to allow EUS guided fine-needle aspiration: safety and effect on patient management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10376454" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Preoperative staging of esophageal carcinoma: miniprobe sonography versus conventional endoscopic ultrasound in a prospective histopathologically verified study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22473575" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Clinicopathological characteristics and prognosis of patients with esophageal carcinoma invading adjacent structures found during esophagectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27810391" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Cancer of the Esophagus and Esophagogastric Junction: An Eighth Edition Staging Primer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7582583" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Assessment of resectability of gastrointestinal cancers by endoscopic ultrasonography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7926534" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Endosonographic features predictive of lymph node metastasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9199903" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration for diagnosis of malignant lymph node invasion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16630763" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Influence of the number of malignant regional lymph nodes detected by endoscopic ultrasonography on survival stratification in esophageal adenocarcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20545976" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Prognostic significance of the endoscopic ultrasound defined lymph node metastasis count in esophageal cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12771883" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32583392" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Comparison of fine-needle aspiration and fine-needle biopsy devices for endoscopic ultrasound-guided sampling of solid lesions: a systemic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9097990" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7601050" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Fine-needle aspiration cytology guided by endoscopic ultrasonography: results in 141 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11726846" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : The utility of EUS and EUS-guided fine needle aspiration in detecting celiac lymph node metastasis in patients with esophageal cancer: a single-center experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10197647" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Esophageal cancer staging: improved accuracy by endoscopic ultrasound of celiac lymph nodes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10533737" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Distant lymph node metastases in esophageal cancer: impact of endoscopic ultrasound-guided biopsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11375583" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Impact of EUS-guided fine-needle aspiration on lymph node staging in patients with esophageal carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10462655" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Evaluation of metastatic celiac axis lymph nodes in patients with esophageal carcinoma: accuracy of EUS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11866287" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : A cost analysis of endoscopic ultrasound in the evaluation of esophageal cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14724814" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Impact of lymph node staging on therapy of esophageal carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16427921" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Routine vs. selective EUS-guided FNA approach for preoperative nodal staging of esophageal carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16733107" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Staging of esophageal carcinoma in a low-volume EUS center compared with reported results from high-volume centers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7720997" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Observer variation and reproducibility of endoscopic ultrasonography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7720984" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : [Evaluation of the teaching of echo-endoscopy. Application to the assessment of invasiveness of cancer of the esophagus and the cardia].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7582582" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Interobserver variation in tumor staging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8836718" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Endosonographic T-staging of esophageal carcinoma: a learning curve.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9109251" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Endoscopic ultrasonography for preoperative staging of esophageal carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10449847" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : The examiner's learning effect and its influence on the quality of endoscopic ultrasonography in carcinoma of the esophagus and gastric cardia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1633774" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Endosonography-guided treatment of esophageal carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25168285" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Staging accuracy of endoscopic ultrasound for esophageal cancer after neoadjuvant chemotherapy: a meta-analysis and systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25088453" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Response evaluation with endoscopic ultrasound and computed tomography in esophageal squamous cell carcinoma treated by definitive chemoradiotherapy.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
